tri-n-butylmethylammonium has been researched along with vecuronium bromide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faber, ED; Meijer, DK; Van Dyke, RW | 1 |
| Meijer, DK; Schinkel, AH; Smit, JW; Weert, B | 2 |
3 other study(ies) available for tri-n-butylmethylammonium and vecuronium bromide
| Article | Year |
|---|---|
Sequestration of organic cations by acidified hepatic endocytic vesicles and implications for biliary excretion.
Topics: Alkaline Phosphatase; Animals; Bile; Cations; Liver; Male; NADH Dehydrogenase; Quaternary Ammonium Compounds; Rats; Rats, Inbred Strains; Tubocurarine; Vecuronium Bromide | 1992 |
Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice in which both mdr1a and mdr1b genes have been disrupted.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Bile; Biological Availability; Cations; Drug Resistance, Multiple; Genes, MDR; Homozygote; Injections, Intravenous; Intestinal Absorption; Intestinal Mucosa; Kidney; Liver; Male; Mice; Quaternary Ammonium Compounds; Vecuronium Bromide | 1998 |
Heterologous expression of various P-glycoproteins in polarized epithelial cells induces directional transport of small (type 1) and bulky (type 2) cationic drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cell Polarity; Epithelium; Quaternary Ammonium Compounds; Swine; Vecuronium Bromide | 1998 |